Sakditad Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared on X:
“Canada, here I comeee!
Excited to share that our abstract on molecular heterogeneity in EGFR-mutant NSCLC has been accepted for the Stowell-Orbison Award Poster Session at USCAP2027 in Vancouver!
Grateful to our team—looking forward to sharing our work!”
You can also read: AMAZE-lung Trial: Triple Targeting With Amivantamab, Lazertinib and Bevacizumab in EGFR-Mutant NSCLC
